IL96531A - History of Acid N- (Diomeric-H1-Pyrolo] D-2,3 [Pyrimidine-3-Ilacyl (-glutamic, preparation and pharmaceutical preparations containing them) - Google Patents

History of Acid N- (Diomeric-H1-Pyrolo] D-2,3 [Pyrimidine-3-Ilacyl (-glutamic, preparation and pharmaceutical preparations containing them)

Info

Publication number
IL96531A
IL96531A IL9653190A IL9653190A IL96531A IL 96531 A IL96531 A IL 96531A IL 9653190 A IL9653190 A IL 9653190A IL 9653190 A IL9653190 A IL 9653190A IL 96531 A IL96531 A IL 96531A
Authority
IL
Israel
Prior art keywords
hydroxy
pyrrolo
hydrogen
ethyl
pyrimidin
Prior art date
Application number
IL9653190A
Other languages
English (en)
Hebrew (he)
Other versions
IL96531A0 (en
Original Assignee
Univ Princeton
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27503964&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL96531(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/528,155 external-priority patent/US5028608A/en
Application filed by Univ Princeton filed Critical Univ Princeton
Publication of IL96531A0 publication Critical patent/IL96531A0/xx
Publication of IL96531A publication Critical patent/IL96531A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL9653190A 1989-12-11 1990-12-04 History of Acid N- (Diomeric-H1-Pyrolo] D-2,3 [Pyrimidine-3-Ilacyl (-glutamic, preparation and pharmaceutical preparations containing them) IL96531A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US44874289A 1989-12-11 1989-12-11
US47965590A 1990-02-08 1990-02-08
US07/528,155 US5028608A (en) 1989-12-11 1990-05-24 N-(6-Amino-(pyrrolo(2,3-d)pyrimidin-3-ylacyl) )-glutamic acid derivatives
US07/528,805 US4996206A (en) 1989-12-11 1990-05-24 N-(pyrrolo[2,3-d]pyrimidin-3-ylacyl)-glutamic acid derivatives

Publications (2)

Publication Number Publication Date
IL96531A0 IL96531A0 (en) 1991-09-16
IL96531A true IL96531A (en) 1995-08-31

Family

ID=27503964

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9653190A IL96531A (en) 1989-12-11 1990-12-04 History of Acid N- (Diomeric-H1-Pyrolo] D-2,3 [Pyrimidine-3-Ilacyl (-glutamic, preparation and pharmaceutical preparations containing them)

Country Status (22)

Country Link
EP (1) EP0432677B1 (ja)
JP (1) JP3016876B2 (ja)
CN (1) CN1030608C (ja)
AR (1) AR245129A1 (ja)
AT (1) ATE135007T1 (ja)
AU (1) AU640182B2 (ja)
CA (1) CA2031890C (ja)
CY (1) CY2076B1 (ja)
DE (2) DE122005000012I2 (ja)
DK (1) DK0432677T3 (ja)
ES (1) ES2084639T4 (ja)
GR (1) GR3019784T3 (ja)
HK (1) HK1000920A1 (ja)
HU (1) HU218483B (ja)
IE (1) IE904445A1 (ja)
IL (1) IL96531A (ja)
LU (1) LU91147I2 (ja)
NL (1) NL300181I2 (ja)
NZ (1) NZ236385A (ja)
PT (1) PT96140B (ja)
RU (1) RU2057131C9 (ja)
SG (1) SG48098A1 (ja)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5254687A (en) 1991-12-04 1993-10-19 The Trustees Of Princeton University Process for the preparation of pyrrolo[2,3-d]pyrimidines
US5235053A (en) * 1992-06-22 1993-08-10 Eli Lilly And Company Process for the synthesis of 4-hydroxy-5-halopyrrold[2,3-d]pyrimidine intermediates
IL163666A0 (en) 2002-02-22 2005-12-18 New River Pharmaceuticals Inc Active agent delivery systems and methods for protecting and administering active agents
CN100344615C (zh) * 2004-11-25 2007-10-24 重庆医药工业研究院有限责任公司 制备N－(吡咯并[2,3－d]嘧啶－5－基)酰基谷氨酸衍生物的方法及中间体
CA2594474C (en) 2005-01-21 2016-03-29 Astex Therapeutics Limited Pharmaceutical compounds
TWI374886B (en) 2006-08-14 2012-10-21 Sicor Inc Processes for preparing intermediates of pemetrexed
DE602007011384D1 (de) 2006-08-14 2011-02-03 Sicor Inc Verfahren zur herstellung lipophiler pharmazeutisch akzeptabler salze aus pemetrexed-disäure
EP2270013A1 (en) 2006-08-14 2011-01-05 Sicor, Inc. Crystalline form of pemetrexed diacid and process for the preparation thereof
WO2008021410A2 (en) 2006-08-14 2008-02-21 Sicor Inc. Highly pure pemetrexed diacid and processes for the preparation thereof
US8916552B2 (en) 2006-10-12 2014-12-23 Astex Therapeutics Limited Pharmaceutical combinations
EP2073807A1 (en) 2006-10-12 2009-07-01 Astex Therapeutics Limited Pharmaceutical combinations
CN101417998B (zh) 2007-10-24 2012-10-24 重庆医药工业研究院有限责任公司 一种培美曲塞盐的纯化方法
JP5993573B2 (ja) * 2008-06-06 2016-09-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 医薬組み合わせ
AU2015210337B2 (en) * 2008-06-06 2017-02-02 Boehringer Ingelheim International Gmbh Pharmaceutical combination
CN101684121B (zh) * 2008-09-22 2013-04-03 重庆医药工业研究院有限责任公司 培美曲塞二酸的新晶型及其制备方法
EP2504341A1 (en) 2009-11-24 2012-10-03 Azad Pharmaceutical Ingredients AG A new crystalline form of pemetrexed disodium
DK2854768T3 (en) 2012-05-30 2017-06-12 Fresenius Kabi Oncology Ltd PHARMACEUTICAL COMPOSITIONS OF PEMETREXED
ITRM20120398A1 (it) 2012-08-08 2014-02-09 Berlin Chemie Ag Procedimento di sintesi pemetrexed e suo sale di lisina.
EP3308770A1 (en) 2013-04-12 2018-04-18 Actavis Group PTC EHF Pemetrexed formulation
WO2014185797A1 (en) 2013-05-17 2014-11-20 Instytut Farmaceutyczny Process for the preparation of high purity amorphous pemetrexed disodium and crystalline forms of n-[4-[2-(2-amino-4,7-dihydro-4-oxo-3h-pyrrolo[2,3- d] pyrimidin-5-yl)ethyl] benzoyl]-l-glutamic acid
ES2657944T3 (es) 2013-06-14 2018-03-07 Synthon B.V. Sal estable de arginina de pemetrexed y composiciones que la comprenden
JP2016527227A (ja) * 2013-07-16 2016-09-08 ドクター レディズ ラボラトリーズ リミテッド ペメトレキセドトロメタミン塩の新規な結晶形
NZ630292A (en) 2013-11-25 2015-02-27 Shilpa Medicare Ltd Process for crystalline pemetrexed dipotassium salt
EA034559B1 (ru) 2014-10-16 2020-02-20 Синтон Б.В. Жидкая фармацевтическая композиция, содержащая пеметрексед
CN104672241B (zh) * 2015-01-29 2018-04-24 王磊 吡咯并[2,3-d]嘧啶类化合物及其用途
FR3037956B1 (fr) * 2015-06-23 2017-08-04 Servier Lab Nouveaux derives d'acide amine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN109195593A (zh) 2016-03-15 2019-01-11 奥莱松基因组股份有限公司 用于治疗实体瘤的lsd1抑制剂的组合
WO2019046612A1 (en) * 2017-08-31 2019-03-07 Duquesne University Of The Holy Spirit INHIBITORS OF FIRST-CATEGORY SHMT2 AND MTHFD2 AS ANTI-TUMOR AGENTS
CN110305136A (zh) * 2018-03-20 2019-10-08 鲁南制药集团股份有限公司 一种培美曲塞二钠中间体及其制备方法
CN110305135B (zh) * 2018-03-20 2022-02-22 鲁南制药集团股份有限公司 一种培美曲塞二钠中间体及其制备方法
CN110305137A (zh) * 2018-03-20 2019-10-08 鲁南制药集团股份有限公司 一种培美曲塞二钠中间体及其制备方法
CN110305134B (zh) * 2018-03-20 2022-02-22 鲁南制药集团股份有限公司 一种培美曲塞二钠中间体及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4818819A (en) * 1986-10-20 1989-04-04 The Trustees Of Princeton University Process for the preparation of fused pyridine compounds
NO169490C (no) * 1988-03-24 1992-07-01 Takeda Chemical Industries Ltd Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolopyrimidinderivater
DK172753B1 (da) * 1988-05-25 1999-06-28 Lilly Co Eli N-(5,6,7,8-tetrahydropyrido[2,3--d]pyrimidin-6-yl-alkanoyl)-glutaminsyrederivater, deres anvendelse, farmaceutiske præparat
US4883799A (en) * 1988-06-29 1989-11-28 The Trustees Of Princeton University N-(4-(1-hydroxy-3-(5,6,7,8-tetrahydropyrido(2,3,-d)-pyrimidin-6-yl)prop-2-yl)benzoyl)glutamic acid derivatives

Also Published As

Publication number Publication date
RU2057131C9 (ru) 2006-04-10
AU640182B2 (en) 1993-08-19
PT96140A (pt) 1991-09-30
AU6779190A (en) 1991-06-13
JP3016876B2 (ja) 2000-03-06
DE69025723D1 (de) 1996-04-11
AR245129A1 (es) 1993-12-30
PT96140B (pt) 1997-06-30
NL300181I2 (nl) 2005-06-01
DK0432677T3 (da) 1996-04-09
CN1055182A (zh) 1991-10-09
HU908147D0 (en) 1991-06-28
ES2084639T4 (es) 2013-06-11
GR3019784T3 (en) 1996-07-31
DE69025723T2 (de) 1996-10-31
CN1030608C (zh) 1996-01-03
CA2031890C (en) 2000-07-25
NL300181I1 (nl) 2005-05-02
JPH083166A (ja) 1996-01-09
CY2076B1 (en) 1998-09-11
EP0432677A1 (en) 1991-06-19
CA2031890A1 (en) 1991-06-12
HK1000920A1 (en) 1998-05-08
IE904445A1 (en) 1991-06-19
HUT58335A (en) 1992-02-28
SG48098A1 (en) 1998-04-17
ATE135007T1 (de) 1996-03-15
HU218483B (hu) 2000-09-28
NZ236385A (en) 1992-05-26
DE122005000012I1 (de) 2005-06-23
IL96531A0 (en) 1991-09-16
EP0432677B1 (en) 1996-03-06
ES2084639T3 (es) 1996-05-16
RU2057131C1 (ru) 1996-03-27
LU91147I2 (fr) 2005-05-17
DE122005000012I2 (de) 2006-02-09

Similar Documents

Publication Publication Date Title
CA2031890C (en) N-(pyrrolo[2,3-d]pyrimidin-3-ylacyl)-glutamic acid derivatives
US5344932A (en) N-(pyrrolo(2,3-d)pyrimidin-3-ylacyl)-glutamic acid derivatives
US4996206A (en) N-(pyrrolo[2,3-d]pyrimidin-3-ylacyl)-glutamic acid derivatives
DK173980B1 (da) Pyrimidinderivater, fremgangsmåde til fremstilling deraf og deres anvendelse som antitumormidler
Taylor et al. A dideazatetrahydrofolate analog lacking a chiral center at C-6: N-[4-[2-(2-amino-3, 4-dihydro-4-oxo-7H-pyrrolo [2, 3-d] pyrimidin-5yl) ethyl [benzoyl]-L-glutamic acid is an inhibitor of thymidylate synthase
US4684653A (en) Pyrido(2,3-d)pyrimidine derivatives
DeGraw et al. Synthesis and antifolate properties of 5, 10-ethano-5, 10-dideazaaminopterin
EP0215063B1 (en) PYRIDO (2,3-d )PYRIMIDIN DERIVATIVES
US4889859A (en) Pyrido[2,3-d]pyrimidine derivatives
US5663339A (en) Process for preparing 5-substituted pyrrolo-[2,3-D] pyrimidines
US4536575A (en) 2-Amino-4(3H)-oxopyrido[2,3-d]pyrimidino
US4833145A (en) 4(3H)-oxo-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidine derivatives
CA2091978A1 (en) Pharmaceutical compounds
US5354754A (en) Pyrrolopyrimidines, their production and use
EP0638079B1 (en) Deazaaminopterins for treatment of inflammation
EP0530579A1 (en) Condensed pyrimidine derivatives antitumor agents
US4526964A (en) 2,4-Diamino-6-(hydroxymethyl)pyrido[2,3-d]pyrimidine
Badawey et al. Synthesis of some new imidazo [1, 2‐a] pyrimidin‐5 (1H)‐ones as potential antineoplastic agents
US5536724A (en) Antiinflammatory and antineoplastic 5-deazaaminopterins and 5,10-dideazaaminopterins
KR950011740B1 (ko) 축합된 피리미딘 유도체
JPH04211063A (ja) 縮合三環性複素環化合物、その製造法、用途及び中間体
EP0075880B1 (en) Pyrido (2,3-d) pyrimidines
Gangjee et al. Synthesis and biological activity of 5, 11-methylenetetrahydro-5-deazahomofolic acid
HU211941A9 (hu) N-(pirrolo[2,3-d]pirimidin-3-ii-acil)-glutaminsav-származékok Az átmeneti oltalom az 1-7. igénypontokra vonatkozik.
WO1997041115A1 (en) 5,6,7,8-TETRAHYDROPYRIDO[2,3-d]PYRIMIDINES

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
EXTP Application for extension order is pending
KB Patent renewed
KB Patent renewed
EXTG Extension of patent term granted
EXTN Extension order renewed
EXTN Extension order renewed
EXTN Extension order renewed
EXTN Extension order renewed